Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated:  1/26/2016
University Dermatology Consultants, Inc., Dermatology Clinical Research Center
mi
from
Cincinnati, OH
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated: 1/26/2016
University Dermatology Consultants, Inc., Dermatology Clinical Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated:  1/26/2016
Radiant Research, Inc
mi
from
Columbus, OH
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated: 1/26/2016
Radiant Research, Inc
mi
from
Columbus, OH
Click here to add this to my saved trials
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated:  1/26/2016
Oregon Medical Research
mi
from
Centre9495 SW Locust St., Suite G Portland, OR
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated: 1/26/2016
Oregon Medical Research
mi
from
Centre9495 SW Locust St., Suite G Portland, OR
Click here to add this to my saved trials
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated:  1/26/2016
Radiant Research, Inc.
mi
from
Anderson, SC
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated: 1/26/2016
Radiant Research, Inc.
mi
from
Anderson, SC
Click here to add this to my saved trials
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated:  1/26/2016
Radiant Research
mi
from
Greer, SC
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated: 1/26/2016
Radiant Research
mi
from
Greer, SC
Click here to add this to my saved trials
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated:  1/26/2016
Dermatology Clinical Research Center of San Antonio
mi
from
San Antonio, TX
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated: 1/26/2016
Dermatology Clinical Research Center of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated:  1/26/2016
Dermatology Associates of Tyler
mi
from
Tyler, TX
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated: 1/26/2016
Dermatology Associates of Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated:  1/26/2016
Dermatology Research Centre
mi
from
Salt Lake City, UT
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated: 1/26/2016
Dermatology Research Centre
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated:  1/26/2016
Skokane Dermatology Clinic, PLLP.
mi
from
Spokane, WA
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.
Status: Enrolling
Updated: 1/26/2016
Skokane Dermatology Clinic, PLLP.
mi
from
Spokane, WA
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
21st Century Oncology - Carolina Regional Cancer Center
mi
from
Myrtle Beach, SC
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
21st Century Oncology - Carolina Regional Cancer Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Abington Memorial Hospital
mi
from
Abington, PA
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
AnMedical Health Cancer Center
mi
from
Anderson, SC
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
AnMedical Health Cancer Center
mi
from
Anderson, SC
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Arizona Cancer Center
mi
from
Scottsdale, AZ
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Arizona Cancer Center
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Cancer Care Northwest
mi
from
Spokane, WA
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Cancer Care Northwest
mi
from
Spokane, WA
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
CaroMont Health Comprehensive Cancer Center
mi
from
Gastonia, NC
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
CaroMont Health Comprehensive Cancer Center
mi
from
Gastonia, NC
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Columbia - St. Mary's
mi
from
Milwaukee, WI
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Columbia - St. Mary's
mi
from
Milwaukee, WI
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Hughes Cancer Center
mi
from
East Stroudsburg, PA
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Hughes Cancer Center
mi
from
East Stroudsburg, PA
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Ironwood Cancer and Research Centers
mi
from
Mesa, AZ
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Ironwood Cancer and Research Centers
mi
from
Mesa, AZ
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
John B. Amos Cancer Center
mi
from
Columbus, GA
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
John B. Amos Cancer Center
mi
from
Columbus, GA
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Lakeland Regional Cancer Center
mi
from
Lakeland, FL
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Lakeland Regional Cancer Center
mi
from
Lakeland, FL
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Mayo Clinic - LaCrosse
mi
from
LaCrosse, WI
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Mayo Clinic - LaCrosse
mi
from
LaCrosse, WI
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Mount Nittany Medical Center
mi
from
State College, PA
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Mount Nittany Medical Center
mi
from
State College, PA
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Northern Indiana Cancer Research Consortium
mi
from
South Bend, IN
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Northern Indiana Cancer Research Consortium
mi
from
South Bend, IN
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Norwalk Hospital
mi
from
Norwalk, CT
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Norwalk Hospital
mi
from
Norwalk, CT
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Parkview Research Center
mi
from
Fort Wayne, IN
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Parkview Research Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Radiation Oncology Associates - Parkview Research Center
mi
from
Fort Wayne, IN
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Radiation Oncology Associates - Parkview Research Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Sanford Health
mi
from
Bismarck, ND
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Sanford Health
mi
from
Bismarck, ND
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Sanford Research/USD
mi
from
Sioux Falls, SD
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Sanford Research/USD
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Spartanburg Regional Medical Center - Gibbs Cancer Center
mi
from
Spartanburg, SC
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Spartanburg Regional Medical Center - Gibbs Cancer Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
St. John Health System
mi
from
Tulsa, OK
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
St. John Health System
mi
from
Tulsa, OK
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
St. Vincent Anderson Regional Hospital Cancer Center
mi
from
Anderson, IN
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
St. Vincent Anderson Regional Hospital Cancer Center
mi
from
Anderson, IN
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
University of Colorado Hospital, Dept. of Radiation Oncology
mi
from
Aurora, CO
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
University of Colorado Hospital, Dept. of Radiation Oncology
mi
from
Aurora, CO
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
University of Nebraska Medical Center Eppley Cancer Center
mi
from
Omaha, NE
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
University of Nebraska Medical Center Eppley Cancer Center
mi
from
Omaha, NE
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated:  1/27/2016
Willis Knighton Cancer Center
mi
from
Shreveport, LA
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis
Status: Enrolling
Updated: 1/27/2016
Willis Knighton Cancer Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
San Diego, CA
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Denver, CO
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Orange Park, FL
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Orange Park, FL
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Tampa, FL
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Arlington Heights, IL
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Carmel, IN
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Carmel, IN
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Ann Arbor, MI
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Verona, NJ
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Verona, NJ
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Albuquerque, NM
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Stony Brook, NY
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
High Point, NC
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Portland, OR
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Austin, TX
A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials